Crosstalk in the retinal neurovascular unit - Lessons for the diabetic retina

Experimental and Clinical Endocrinology and Diabetes

Volumn 120, Issue 4, 2012, Pages 199-201

  Feng, Y ^a   Busch, S ^a   Gretz, N ^a   Hoffmann, S ^a   Hammes, H P ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

diabetes; neuropathy; oxidative stress; reknopathy

Indexed keywords

ERYTHROPOIETIN; NERVE GROWTH FACTOR; POLYCYSTIN;

APOPTOSIS; CELL LOSS; COMPLEMENT SYSTEM; DEGENERATIVE DISEASE; DIABETIC RETINOPATHY; GENE EXPRESSION; GLIA; HUMAN; INNATE IMMUNITY; MOLECULAR INTERACTION; NERVE CELL; NONHUMAN; PHOTORECEPTOR; PRIORITY JOURNAL; PROLIFERATIVE RETINOPATHY; RETINAL NEUROVASCULAR UNIT; REVIEW; TRANSGENIC ANIMAL; WARD;

ADULT; ANIMALS; BLOOD VESSELS; CELL COMMUNICATION; DIABETIC RETINOPATHY; HUMANS; NEURONS; RATS; RATS, TRANSGENIC; RECEPTOR CROSS-TALK; RETINA; RETINAL VESSELS; SIGNAL TRANSDUCTION;

EID: 84860261166     PISSN: 09477349     EISSN: 14393646     Source Type: Journal    
DOI: 10.1055/s-0032-1304571     Document Type: Review

References (27)

1. Cheung N, Mitchell P, Wong T Y. Diabetic retinopathy. Lancet 376 124 136
2. Tang J, Kern T S. Inflammation in diabetic retinopathy. Prog Retin Eye Res 30 343 358
3. Silva P S, Cavallerano J D, Sun J K et al. Effect of systemic medications on onset and progression of diabetic retinopathy. Nat Rev Endocrinol. 6 494-508
4. Antonetti D A, Barber A J, Bronson S K et al. Diabetic retinopathy: seeing beyond glucose-induced microvascular disease. Diabetes: 2006; 55 2401 2411 (Pubitemid 44871140)
5. Hammes H P, Federoff H J, Brownlee M. Nerve growth factor prevents both neuroretinal programmed cell death and capillary pathology in experimental diabetes. Mol Med: 1995; 1 527 534
6. Aizu Y, Oyanagi K, Hu J et al. Degeneration of retinal neuronal processes and pigment epithelium in the early stage of the streptozotocin-diabetic rats. Neuropathology: 2002; 22 161 170 (Pubitemid 35252706)
7. Barber A J, Lieth E, Khin S A et al. Neural apoptosis in the retina during experimental and human diabetes. Early onset and effect of insulin. J Clin Invest: 1998; 102 783 791 (Pubitemid 28399611)
8. Wang Q, Gorbey S, Pfister F et al. Long-term treatment with suberythropoietic Epo is vaso- and neuroprotective in experimental diabetic retinopathy. Cell Physiol Biochem 27 769 782
9. Brownlee M. The pathobiology of diabetic complications: a unifying mechanism. Diabetes: 2005; 54 1615 1625 (Pubitemid 40770750)
10. Du Y, Miller C M, Kern T S. Hyperglycemia increases mitochondrial superoxide in retina and retinal cells. Free Radic Biol Med: 2003; 35 1491 1499 (Pubitemid 37452474)
11. Wang Y, Vom Hagen F, Pfister F et al. Receptor for advanced glycation end product expression in experimental diabetic retinopathy. Ann N Y Acad Sci: 2008; 1126 42 45 (Pubitemid 351589325)
12. Hammes H P, Feng Y, Pfister F et al. Diabetic retinopathy: targeting vasoregression. Diabetes. 60 9-16
13. Pannicke T, Iandiev I, Wurm A et al. Diabetes alters osmotic swelling characteristics and membrane conductance of glial cells in rat retina. Diabetes: 2006; 55 633 639 (Pubitemid 43343219)
14. Krady J K, Basu A, Allen C M et al. Minocycline reduces proinflammatory cytokine expression, microglial activation, and caspase-3 activation in a rodent model of diabetic retinopathy. Diabetes: 2005; 54 1559 1565 (Pubitemid 40586690)
15. McVicar C M, Hamilton R, Colhoun L M et al. Intervention with an erythropoietin-derived peptide protects against neuroglial and vascular degeneration during diabetic retinopathy. Diabetes 60 2995 3005
16. Gallagher A R, Hoffmann S, Brown N et al. A truncated polycystin-2 protein causes polycystic kidney disease and retinal degeneration in transgenic rats. J Am Soc Nephrol: 2006; 17 2719 2730 (Pubitemid 44484662)
17. Feng Y, Wang Y, Stock O et al. Vasoregression linked to neuronal damage in the rat with defect of polycystin-2. PLoS One: 2009; 4 e7328
18. Feng Y, Wang Y, Li L et al. Gene expression profiling of vasoregression in the retina - involvement of microglial cells. PLoS One. 6 e16865
19. Hammes H P, Lin J, Wagner P et al. Angiopoietin-2 causes pericyte dropout in the normal retina: evidence for involvement in diabetic retinopathy. Diabetes: 2004; 53 1104 1110 (Pubitemid 38436625)
20. Zheng L, Kern T S. Role of nitric oxide, superoxide, peroxynitrite and PARP in diabetic retinopathy. Front Biosci: 2009; 14 3974 3987
21. Li G, Tang J, Du Y et al. Beneficial effects of a novel RAGE inhibitor on early diabetic retinopathy and tactile allodynia. Mol Vis 17 3156 3165
22. Kumar S, Zhuo L. Longitudinal in vivo imaging of retinal gliosis in a diabetic mouse model. Exp Eye Res 91 530 536
23. Park S H, Park J W, Park S J et al. Apoptotic death of photoreceptors in the streptozotocin-induced diabetic rat retina. Diabetologia: 2003; 46 1260 1268
24. Barber A J, Antonetti D A, Kern T S et al. The Ins2Akita mouse as a model of early retinal complications in diabetes. Invest Ophthalmol Vis Sci: 2005; 46 2210 2218
25. Hammes H P, Lin J, Bretzel R G et al. Upregulation of the vascular endothelial growth factor/vascular endothelial growth factor receptor system in experimental background diabetic retinopathy of the rat. Diabetes: 1998; 47 401 406 (Pubitemid 28104202)
26. Kubota S, Ozawa Y, Kurihara T et al. Roles of AMP-Activated Protein Kinase in Diabetes-Induced Retinal Inflammation. Invest Ophthalmol Vis Sci 52 9142 9148
27. Gaucher D, Chiappore J A, Paques M et al. Microglial changes occur without neural cell death in diabetic retinopathy. Vision Res: 2007; 47 612 623 (Pubitemid 46242159)